We monitored the proliferation of EGFR mutation lung cancer cell lines H1650, H1975, and HCC827 using a Real-Time Cellular Analyzer (RTCA) under simultaneous treatment with rHuEPO and Afatinib, which we compared to Afatinib treatment alone. This evidence concerns the gene EGFR and lung cancer.